spacer
home > ebr > spring 2019 > connecting erp and rim data
PUBLICATIONS
European Biopharmaceutical Review

Connecting ERP and RIM Data

The more readily different parts of life sciences organisations can share good quality data, the greater the benefits for everyone concerned. However, all of this relies on an ability to harness the right data at the right time as a useful asset. As long as data is entered in different ways into different systems and in functional siloes, the scope for improving productivity and efficiency and delivering strategic business benefits will be limited. What other options are available and what is involved in a ‘master data management’ approach?

Improved data exchange was the subject of a recent roundtable debate among experienced industry experts. On the panel were Steve Gens, managing partner at Gens & Associates, Kelly Hnat, Principal at K2 Consulting, Jesper Kihl, Vice President for Global Regulatory Affairs at LEO Pharm, Jan Vindberg-Larsen, Senior Director and Head of Global Regulatory Affairs at Lundbeck, Erick Gaussens PhD, Chief Scientific Officer at ProductLife Group (PLG), Catherine Gambert, Senior Consultant for Regulatory Affairs and Regulatory Information at PLG, and Loetitia Jabri, Regulatory and Pharmaceutical Platforms Associate Director at PLG.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Erick Gaussens PhD is co-founder, Principal Consultant, and Chief Scientific Officer at ProductLife Group, providing deep insights into risk management and regulatory sciences in the life sciences industry, as well as expertise in cognitive science.
spacer
Eric Gaussens PhD
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo maintains its steady growth.

According to the data obtained by WACD, the international air cargo information provider, in May; Turkish Cargo, the global air cargo brand providing service to 124 countries around the world, increased its tonnage rate by 7.1 percent, and grew substantially across the industry which shrank by 5.1 percent in the global air cargo market.
More info >>

White Papers

The BioPharmaSpec Approach”: Mass Spectrometry Based Host Cell Protein Identification and Quantitation

BioPharmaSpec

1. Introduction As part of the development of any biopharmaceutical product, the impurities present must be examined, minimized and where possible characterized (1). These impurities fall into two broad categories: product-related impurities (derived specifically from the drug product itself) and process-related impurities (derived from material associated with the production, processing or purification of the sample). Host cell proteins (HCPs) are process-related impurities that require specific analysis due to the multitude of naturally occurring proteins expressed in the production cell line.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement